Guyana’s Ministry of Health rejects claims that medicines worth about G$7.7 billion were not received. The ministry says the medicines were supplied by contractors and were received and accepted.

Both reports point to problems in how the inventory was recorded during an operational change. The Guyana Chronicle says the discrepancy cited by the Auditor General stems from delays in entering deliveries into a new electronic inventory system, rather than a failure to supply. INews Guyana adds that the Ministry was implementing CORTEX, its supply chain management software, and that the transition caused a recording backlog at the time of the Auditor General’s checks.

The outlets’ emphasis differs in framing—one focuses on the electronic inventory entry delays, while the other foregrounds the CORTEX software transition—but the core contention is consistent across sources: supply and acceptance of the medicines are not disputed, while record-keeping timing during system rollout is presented as the explanation.